InvestorsHub Logo
Followers 8
Posts 387
Boards Moderated 0
Alias Born 03/19/2018

Re: None

Tuesday, 12/21/2021 11:08:47 AM

Tuesday, December 21, 2021 11:08:47 AM

Post# of 44695
Perhaps the Jewish Fund had negative info on NRXP ability to bring Brilife to market. It conflicts with the CA and would have to be updated to keep up with viral mutations